HBV-IN-52

HBV-IN-52 is a selective inhibitor of HBV and a derivative of Neplanocin A, displaying significant anti-hepatitis B virus replication activity with an EC50 of 0.96 μM. It also suppresses the secretion of hepatitis B surface antigen (HBsAg) with an EC50 of 0.82 μM. HBV-IN-52 is useful for studying chronic hepatitis B (CHB) infection.